Ml. Sentman et al., Enhanced alloxan-induced beta-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular-superoxide dismutase, FREE RAD B, 27(7-8), 1999, pp. 790-796
Alloxan is a diabetogenic agent which apparently acts through formation of
superoxide radicals formed by redox cycling. Superoxide radicals are also f
ormed by a variety of mechanisms in hyperglycemia. We exposed extracellular
-superoxide dismutase (EC-SOD) null mutant and wild-type mice to alloxan, a
nd followed up both the initial diabetes induction and the long-term course
of the hyperglycemia. The null mutant mice responded with a modestly enhan
ced hyperglycemia compared to the wild type controls. In the long-term foll
ow-up all mice eventually regained glycemic control, although it took longe
r for individuals with higher initial hyperglycemia. This delaying effect o
f the hyperglycemia was much more pronounced in the null mutant mice. These
data suggest that the difference in initial diabetes induction between the
groups is due to interception by EC-SOD of extracellular superoxide radica
ls produced by alloxan. The delayed recovery in the null mutant mice sugges
ts that superoxide radicals released as a result of hyperglycemia impair be
ta-cell regeneration and that EC-SOD provides some protection. Mouse islets
were found to contain Little EC-SOD, whereas the content of the cytosolic
Cu- and Zn-containing SOD was very high. This low EC-SOD activity may contr
ibute to the high alloxan susceptibility of beta-cells, and may also cause
a high susceptibility to superoxide radicals produced by activated inflamma
tory leukocytes and in hyperglycemia. (C) 1999 Elsevier Science Inc.